Toggle navigation
Home
Search
Services
Blog
Contact
About
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry
University of Illinois at Chicago, Chicago, IL, United States
Search 87 grants from Barry Levin
Search grants from University of Illinois at Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
HIV/AIDS Surveillance
Hyperglycemia and Pregnancy Outcome(HAPO)Follow Up Study
Inhibitory Control of Prefrontal Cortex
Gene-Augmented Mesenchymal Stem Cells in Bone Repair
Mechanisms of Transcriptional Repression by AML1-Eto
Recently added grants:
Administrative and Faculty Development Core
Transgenic Animal Genotyping and Phenotyping Core
High Spatial and Temporal Resolution Imaging Core
The impact of sarcomere protein acetylation in heart failure
PDGFRalpha+ fibroblast-like cells contribute to cardiac excitability
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN015352-001
Application #
3617530
Study Section
Project Start
1991-09-30
Project End
Budget Start
1991-09-30
Budget End
1993-09-29
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chicago
Department
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Related projects
NIH 1992
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
NIH 1992
N01 CN
Preclinical Toxicology Studies Ws#24 and #25
Levine, Barry S. / University of Illinois at Chicago
NIH 1991
N01 CN
13 Week Oral Subchronic Toxicity in Rats & Dogs Applied
Levin, Barry / University of Illinois at Chicago
Publications
Crowell, James A; Page, John G; Levine, Barry S et al.
(2006)
Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450.
Toxicol Appl Pharmacol 211:115-23
Comments
Be the first to comment on Barry Levin's grant